Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Stoke Therapeutics granted stock options to purchase 106,200 shares to eight new employees as a material inducement to employment. The grants were effective May 15, 2026, with an exercise price of $30.08, which matched the closing stock price on that date.
Key figures
- Offering Price
- 30.08
- Shares Offered
- 106200
- Grant date
- 2026-05-15
- Option term
- 10 years
- Vesting period
- 4 years
- Number of recipients
- 8
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.